--- title: "AirSculpt Tech | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 42.9 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/295389467.md" datetime: "2026-08-10T10:11:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295389467.md) - [en](https://longbridge.com/en/news/295389467.md) - [zh-HK](https://longbridge.com/zh-HK/news/295389467.md) generator: "portal-rs" --- # AirSculpt Tech | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 42.9 M Revenue: As of FY2026 Q2, the actual value is USD 42.9 M, missing the estimate of USD 44.14 M. EPS: As of FY2026 Q2, the actual value is USD -0.02. EBIT: As of FY2026 Q2, the actual value is USD 1.014 M. ### Second Quarter 2026 Financial Highlights #### Revenue AirSculpt Technologies, Inc. reported revenue of $42.9 million for the second quarter of 2026, marking a -3% decrease from $44.0 million in the fiscal year 2025 second quarter. #### Net Loss The net loss for the quarter was - $1.1 million, compared to a net loss of - $0.6 million in the fiscal year 2025 second quarter. #### Adjusted EBITDA Adjusted EBITDA was $4.9 million, down from $5.8 million in the fiscal year 2025 second quarter. #### Adjusted EBITDA Margin The Adjusted EBITDA margin was 11.5% for Q2 2026, compared to 13.3% for Q2 2025. #### Loss from Operations The company reported a loss from operations of - $29 thousand for Q2 2026, compared to an income from operations of $786 thousand in Q2 2025. #### Interest Expense, Net Net interest expense was $1,043 thousand in Q2 2026, down from $1,562 thousand in Q2 2025. #### Operating Costs Total operating expenses were $42,929 thousand in Q2 2026, a decrease from $43,226 thousand in Q2 2025. Cost of service was $16,567 thousand in Q2 2026, down from $17,201 thousand in Q2 2025. Selling, general and administrative expenses increased to $23,421 thousand in Q2 2026 from $22,671 thousand in Q2 2025. Depreciation and amortization was $2,941 thousand in Q2 2026, compared to $3,246 thousand in Q2 2025. ### First Six Months 2026 Financial Highlights #### Revenue Revenue for the first six months of 2026 declined by -1.3% to $82.3 million from $83.4 million in the first six months of fiscal year 2025. #### Net Loss Net loss for the first six months was - $3.5 million, compared to - $3.4 million in the first six months of fiscal year 2025. #### Adjusted EBITDA Adjusted EBITDA was $8.2 million, down from $9.6 million in the first six months of fiscal year 2025. #### Adjusted EBITDA Margin The Adjusted EBITDA margin was 10.0% for YTD 2026, compared to 11.5% for YTD 2025. #### Loss from Operations The company reported a loss from operations of - $1,831 thousand for YTD 2026, compared to a loss of - $803 thousand in YTD 2025. #### Interest Expense, Net Net interest expense was $2,241 thousand in YTD 2026, down from $3,187 thousand in YTD 2025. #### Operating Costs Total operating expenses were $84,120 thousand in YTD 2026, a decrease from $84,186 thousand in YTD 2025. Cost of service was $32,155 thousand in YTD 2026, down from $33,151 thousand in YTD 2025. Selling, general and administrative expenses increased to $46,003 thousand in YTD 2026 from $44,439 thousand in YTD 2025. Depreciation and amortization was $5,962 thousand in YTD 2026, compared to $6,488 thousand in YTD 2025. ### Operational Metrics #### Case Volume Case volume was 3,376 for Q2 2026, a -0.5% decrease from 3,392 in Q2 2025. For the first six months of 2026, case volume was 6,458, a -0.2% decrease from 6,468 in the prior year period. #### Same Center Case Volume Same center case volume grew by 1.0% in Q2 2026 and 1.1% year-to-date. #### Same Center Sales Same center sales were stable in Q2 2026 and flat year-to-date. #### Revenue per Case Revenue per case was $12,707 in Q2 2026, down from $12,975 in Q2 2025. For YTD 2026, revenue per case was $12,742, compared to $12,892 in YTD 2025. #### Number of Facilities As of June 30, 2026, the company operated 31 facilities, down from 32 facilities as of June 30, 2025. #### Number of Total Procedure Rooms The number of total procedure rooms was 65 as of June 30, 2026, compared to 67 as of June 30, 2025. #### Strategic Initiatives AirSculpt Technologies, Inc. advanced its plans to introduce new procedures, including an exclusive partnership with AlloClae to offer an innovative injectable adipose matrix. ### Cash Flow Data #### Net Cash Provided by (Used in) Operating Activities For Q2 2026, net cash used in operating activities was - $1,238 thousand, compared to $4,984 thousand provided by operating activities in Q2 2025. For the first six months of 2026, net cash provided by operating activities was $4,033 thousand, down from $5,852 thousand in the prior year period. #### Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities was - $228 thousand in Q2 2026, compared to - $265 thousand in Q2 2025. For the first six months of 2026, net cash used in investing activities was - $279 thousand, a decrease from - $2,166 thousand in the prior year period. #### Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities was $3,600 thousand in Q2 2026, compared to - $2,083 thousand used in financing activities in Q2 2025. For the first six months of 2026, net cash provided by financing activities was $6,621 thousand, compared to - $3,732 thousand used in financing activities in the prior year period. ### Balance Sheet and Liquidity (as of June 30, 2026) #### Cash and Cash Equivalents The company had $18,824 thousand in cash and cash equivalents, an increase from $8,449 thousand as of December 31, 2025. #### Gross Debt Gross debt was approximately $44.2 million, following a reduction of approximately $30 million since the start of 2025. #### Current Portion of Long-Term Debt The current portion of long-term debt was $10,460 thousand, up from $5,460 thousand as of December 31, 2025. #### Long-Term Debt, Net Long-term debt, net, was $33,108 thousand, down from $50,585 thousand as of December 31, 2025. #### Total Liabilities Total liabilities were $88,449 thousand, compared to $99,592 thousand as of December 31, 2025. #### Total Stockholders’ Equity Total stockholders’ equity increased to $104,832 thousand from $87,712 thousand as of December 31, 2025. #### Borrowing Capacity AirSculpt Technologies, Inc. had $5.0 million of borrowing capacity under its revolving credit facility. #### Debt Repayment During Q2 2026, the company paid down $1.4 million of debt and raised an additional $5.0 million from an at-the-market offering program. On August 7, 2026, a $2.5 million term loan payment was made in connection with an amended term loan agreement extending its maturity to November 2027, with an additional $2.5 million payment required by September 30, 2026. ### 2026 Outlook AirSculpt Technologies, Inc. is reaffirming its full year 2026 revenue at the lower end of its guidance range of approximately $151 million to $157 million. The company is reducing its adjusted EBITDA outlook to the range of approximately $12 million to $14 million. These forward-looking statements are subject to various risks and uncertainties. ### Related Stocks - [AIRS.US](https://longbridge.com/en/quote/AIRS.US.md) ## Related News & Research - [AirSculpt Q2 revenue falls more than expected](https://longbridge.com/en/news/295389428.md) - [AirSculpt Technologies Relocates Corporate Headquarters to Tampa](https://longbridge.com/en/news/295650827.md) - [AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results | AIRS Stock News](https://longbridge.com/en/news/284886473.md) - [AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity](https://longbridge.com/en/news/295585707.md) - [AirSculpt Technologies Balances Stabilization With Near-Term Strains](https://longbridge.com/en/news/296690644.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**